prednisolone has been researched along with Lung Diseases, Obstructive in 103 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of oral prednisolone on the lung function of 20 adult patients with cystic fibrosis who had severe stable airflow obstruction was assessed in a placebo controlled study, blind to the patients." | 9.06 | Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis. ( Batten, JC; Hodson, ME; Pantin, CF; Stead, RJ, 1986) |
| "To report a case of bupropion-induced drug rash with eosinophilia and systemic symptoms syndrome, including acute hepatitis, obstructive lung disease, and myositis." | 7.72 | Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration. ( Bagshaw, SM; Bowen, TJ; Cload, B; Gilmour, J; Leung, ST, 2003) |
| "Antibiotics given with a short course of oral prednisolone during an exacerbation do not accelerate recovery as measured by changes in peak flow and symptom scores in ambulatory patients with mild to moderate asthma or COPD when treated by their general practitioners." | 5.08 | Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. ( Groenier, KH; Koëter, GH; Meyboom-de Jong, B; Sachs, AP; Schiphuis, J; van der Waaij, D, 1995) |
| " Thirty-four outpatients with symptomatic asthma or chronic obstructive airways disease (COAD) receiving long-term oral prednisolone (mean 10." | 5.08 | Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels. ( Burrin, J; Hattersley, A; Ibbertson, K; Meeran, K; Shiner, R, 1995) |
| " Because the lack of anti-inflammatory effect might have been due to poor drug delivery as a result of severe airflow limitation, we undertook a study examining the antiinflammatory effect of oral prednisolone (30 mg daily for 2 wk) in patients with COPD and undertook the same measurements in 10 patients with atopic asthma." | 5.08 | Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. ( Barnes, PJ; Jatakanon, A; Keatings, VM; Worsdell, YM, 1997) |
| "The effect of oral prednisolone on the lung function of 20 adult patients with cystic fibrosis who had severe stable airflow obstruction was assessed in a placebo controlled study, blind to the patients." | 5.06 | Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis. ( Batten, JC; Hodson, ME; Pantin, CF; Stead, RJ, 1986) |
| "To report a case of bupropion-induced drug rash with eosinophilia and systemic symptoms syndrome, including acute hepatitis, obstructive lung disease, and myositis." | 3.72 | Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration. ( Bagshaw, SM; Bowen, TJ; Cload, B; Gilmour, J; Leung, ST, 2003) |
| "Twelve patients with chronic severe asthma, taking a mean daily dosage of 8 mg of prednisolone for a mean (SD) of 16." | 3.68 | Sternomastoid muscle fatigue and twitch maximum relaxation rate in patients with steroid dependent asthma. ( Bugler, JR; Mak, VH; Spiro, SG, 1993) |
| "To determine whether asthma alone can cause irreversible airflow obstruction 42 men and 47 women with chronic asthma (mean duration 22 (SD 13) years) without evidence of other disease likely to cause irreversible airflow obstruction were treated with theophylline orally and a beta agonist both orally and by inhalation for four weeks." | 3.67 | Asthma and irreversible airflow obstruction. ( Brown, PJ; Finucane, KE; Greville, HW, 1984) |
| "Prednisolone was shown, for the first time, to our knowledge, to improve the pulmonary function of horses with RAO in the presence of continuous antigen exposure." | 2.75 | Efficacy of oral prednisolone and dexamethasone in horses with recurrent airway obstruction in the presence of continuous antigen exposure. ( Beauchamp, G; Lavoie, JP; Leclere, M; Lefebvre-Lavoie, J, 2010) |
| "The adverse effects of oral corticosteroids are widely recognised but there are few quantitative data on which to base advice to patients." | 2.70 | Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. ( Cooper, S; Hubbard, R; Lewis, SA; Oborne, J; Pringle, M; Tattersfield, AE; Walsh, LJ; Wong, CA, 2001) |
| " We conclude that the therapeutic effects of steroid therapy may be achieved by the long-term use of high-dose, inhaled corticosteroid in some patients with stable COPD." | 2.69 | Additive effects of prednisolone and beclomethasone dipropionate in patients with stable chronic obstructive pulmonary disease. ( Hajiro, T; Ikeda, A; Izumi, T; Koyama, H; Nishimura, K; Tsukino, M; Zhang, M, 2000) |
| "The prognosis of chronic eosinophilic pneumonia (CEP) is usually good under corticosteroid therapy (CST)." | 1.30 | Long-term follow-up of pulmonary function in chronic eosinophilic pneumonia. Groupe d'Etude en Pathologie Interstitielle de la Société de Pathologie Thoracique du Nord. ( Durieu, J; Tonnel, AB; Wallaert, B, 1997) |
| "Leukotriene E4 was measured by high performance liquid chromatography (HPLC) and radioimmunoassay." | 1.30 | Plasma levels of leukotriene E4 during clinical course of chronic obstructive pulmonary disease. ( Fukumura, M; Hirai, Y; Koide, K; Shindo, K, 1997) |
| "016) with the current glucocorticoid dosage (r=-0." | 1.30 | Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. ( Behre, HM; Castel, MA; Kamischke, A; Kemper, DE; Lüthke, M; Magnussen, H; Nieschlag, E; Rolf, C, 1998) |
| "Oral clenbuterol was effective in only seven of 15 cases." | 1.29 | Obstructive pulmonary disease in 18 horses at summer pasture. ( Mair, TS, 1996) |
| "Short courses of prednisolone increased bone resorption and inhibited bone formation after two and four weeks." | 1.28 | Bone turnover during short course prednisolone treatment in patients with chronic obstructive airways disease. ( Ali, NJ; Capewell, S; Morrison, D; Routledge, PA, 1992) |
| " The four patterns of FEV1 showed a strong association with the long-term use of prednisolone." | 1.27 | Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction? ( Peters, I; Postma, DS; Sluiter, HJ; Steenhuis, EJ, 1988) |
| " The 3 patterns of FEV1 showed strong association with the long-term use of prednisolone." | 1.27 | Severe chronic airflow obstruction: can corticosteroids slow down progression? ( Postma, DS; Sluiter, HJ; Steenhuis, EJ; van der Weele, LT, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 44 (42.72) | 18.7374 |
| 1990's | 48 (46.60) | 18.2507 |
| 2000's | 9 (8.74) | 29.6817 |
| 2010's | 2 (1.94) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, SC | 1 |
| Chu, YH | 1 |
| Kao, CH | 1 |
| Wu, CC | 1 |
| Wang, HW | 1 |
| Leclere, M | 1 |
| Lefebvre-Lavoie, J | 1 |
| Beauchamp, G | 1 |
| Lavoie, JP | 1 |
| Bagshaw, SM | 1 |
| Cload, B | 1 |
| Gilmour, J | 1 |
| Leung, ST | 1 |
| Bowen, TJ | 1 |
| Couroucé-Malblanc, A | 1 |
| Fortier, G | 1 |
| Pronost, S | 1 |
| Siliart, B | 1 |
| Brachet, G | 1 |
| Stokes, TC | 1 |
| Shaylor, JM | 1 |
| O'Reilly, JF | 1 |
| Harrison, BD | 1 |
| Rudd, R | 1 |
| Gellert, A | 1 |
| Empey, D | 1 |
| Mitchell, DM | 3 |
| Gildeh, P | 3 |
| Rehahn, M | 2 |
| Dimond, AH | 2 |
| Collins, JV | 4 |
| Curzon, PG | 1 |
| Martin, MA | 1 |
| Cooke, NJ | 3 |
| Muers, MF | 2 |
| Webb, J | 2 |
| Clark, TJ | 2 |
| Lam, WK | 1 |
| So, SY | 1 |
| Yu, DY | 1 |
| Rudolf, M | 1 |
| Dimond, A | 1 |
| Haines, JF | 1 |
| Kamat, SR | 1 |
| Hoskote, VR | 1 |
| Jagasia, RS | 1 |
| Shah, DC | 1 |
| Tyagi, NK | 1 |
| Thomas, TP | 1 |
| Brown, PJ | 1 |
| Greville, HW | 1 |
| Finucane, KE | 2 |
| Chilvers, C | 1 |
| Sachs, AP | 1 |
| Koëter, GH | 3 |
| Groenier, KH | 1 |
| van der Waaij, D | 1 |
| Schiphuis, J | 1 |
| Meyboom-de Jong, B | 1 |
| Grove, A | 1 |
| Lipworth, BJ | 1 |
| Ingram, CG | 1 |
| Clark, RA | 1 |
| Dhillon, DP | 1 |
| Koyama, H | 3 |
| Nishimura, K | 3 |
| Ikeda, A | 2 |
| Tsukino, M | 2 |
| Izumi, T | 3 |
| Morrison, D | 2 |
| Capewell, S | 3 |
| Reynolds, SP | 1 |
| Thomas, J | 1 |
| Ali, NJ | 2 |
| Read, GF | 1 |
| Henley, R | 1 |
| Riad-Fahmy, D | 1 |
| Meeran, K | 1 |
| Hattersley, A | 1 |
| Burrin, J | 1 |
| Shiner, R | 1 |
| Ibbertson, K | 1 |
| Mak, VH | 1 |
| Bugler, JR | 1 |
| Spiro, SG | 1 |
| Tandon, MK | 1 |
| Weir, DC | 5 |
| Burge, PS | 7 |
| Renkema, TE | 2 |
| Schouten, JP | 2 |
| Postma, DS | 4 |
| Mair, TS | 1 |
| Walsh, LJ | 2 |
| Wong, CA | 2 |
| Pringle, M | 2 |
| Tattersfield, AE | 3 |
| Hatton, MQ | 1 |
| Allen, MB | 1 |
| Vathenen, SV | 1 |
| Feely, MP | 1 |
| Hjalmarsen, A | 1 |
| Aasebø, U | 1 |
| Aleksandersen, G | 1 |
| Jorde, R | 1 |
| Morice, AH | 1 |
| Morris, D | 1 |
| Lawson-Matthew, P | 1 |
| Keatings, VM | 1 |
| Jatakanon, A | 1 |
| Worsdell, YM | 1 |
| Barnes, PJ | 1 |
| Durieu, J | 1 |
| Wallaert, B | 1 |
| Tonnel, AB | 1 |
| Shindo, K | 1 |
| Hirai, Y | 1 |
| Fukumura, M | 1 |
| Koide, K | 1 |
| Hsu, JY | 1 |
| Huang, CM | 1 |
| King, SL | 1 |
| Chiang, CD | 2 |
| Rahman, I | 1 |
| Skwarska, E | 1 |
| MacNee, W | 1 |
| Wu, CL | 1 |
| Hsu, WH | 1 |
| Kamischke, A | 1 |
| Kemper, DE | 1 |
| Castel, MA | 1 |
| Lüthke, M | 1 |
| Rolf, C | 1 |
| Behre, HM | 1 |
| Magnussen, H | 2 |
| Nieschlag, E | 1 |
| Corden, Z | 1 |
| Rees, PJ | 1 |
| Ravn, HB | 1 |
| Dørup, I | 1 |
| Bourbeau, J | 1 |
| Rouleau, MY | 1 |
| Boucher, S | 1 |
| Löfdahl, CG | 1 |
| Kerstjens, HA | 1 |
| Vonk, JM | 1 |
| Votion, D | 1 |
| Ghafir, Y | 1 |
| Vandenput, S | 1 |
| Duvivier, DH | 1 |
| Art, T | 1 |
| Lekeux, P | 1 |
| Davies, L | 2 |
| Angus, RM | 1 |
| Calverley, PM | 4 |
| Ishii, T | 1 |
| Matsuse, T | 1 |
| Richter, K | 1 |
| Holz, O | 1 |
| Jörres, RA | 1 |
| Mücke, M | 1 |
| Senderovitz, T | 1 |
| Vestbo, J | 1 |
| Frandsen, J | 1 |
| Maltbaek, N | 1 |
| Nørgaard, M | 1 |
| Nielsen, C | 1 |
| Kampmann, JP | 1 |
| Nisar, M | 3 |
| Pearson, MG | 3 |
| Costello, RW | 1 |
| Earis, JE | 3 |
| Griffiths, C | 1 |
| Feder, G | 1 |
| Wedzicha, J | 1 |
| Foster, G | 1 |
| Livingstone, A | 1 |
| Marlowe, GS | 1 |
| Polosa, R | 1 |
| Wedzicha, JA | 1 |
| Pouw, EM | 1 |
| Koerts-de Lang, E | 1 |
| Gosker, HR | 1 |
| Freling, G | 1 |
| van der Vusse, GJ | 1 |
| Wouters, EF | 1 |
| Schols, AM | 1 |
| Zhang, M | 1 |
| Hajiro, T | 1 |
| Brown, HM | 1 |
| Oborne, J | 1 |
| Cooper, S | 1 |
| Lewis, SA | 1 |
| Hubbard, R | 1 |
| Harrison, TW | 1 |
| Mue, S | 1 |
| Takahashi, M | 1 |
| Ohmi, T | 1 |
| Okayama, H | 1 |
| Shibahara, S | 1 |
| Yamauchi, K | 1 |
| Fujimoto, S | 1 |
| Tamura, G | 1 |
| Takishima, T | 1 |
| Sluiter, HJ | 4 |
| Berg, WC | 1 |
| Steenhuis, EJ | 3 |
| Wesseling, H | 1 |
| de Vries, K | 3 |
| Sedlarik, K | 1 |
| Kirsten, D | 1 |
| Meister, W | 2 |
| Mio, T | 1 |
| Routledge, PA | 1 |
| Adair, CG | 1 |
| McCallion, O | 1 |
| McElnay, JC | 1 |
| Scott, MG | 1 |
| Hamilton, BA | 1 |
| McCann, JP | 1 |
| Stanford, CF | 1 |
| Nicholls, DP | 1 |
| Morrison, JF | 1 |
| Jones, PC | 1 |
| Pomerantsev, VP | 1 |
| Gove, RI | 5 |
| Robertson, AS | 5 |
| Wiggins, J | 1 |
| Feher, MD | 1 |
| Lant, AF | 1 |
| Tebbe, B | 1 |
| Mayer-da-Silva, A | 1 |
| Garbe, C | 1 |
| von Keyserlingk, HJ | 1 |
| Orfanos, CE | 1 |
| Hens, C | 1 |
| Böhning, W | 1 |
| Walshaw, M | 1 |
| Reynolds, S | 1 |
| Shuttleworth, D | 1 |
| Edwards, C | 1 |
| Finlay, AY | 1 |
| Zimmermann, I | 1 |
| Bugalho de Almeida, AA | 1 |
| Schött, D | 1 |
| Schwabl, H | 1 |
| Ulmer, WT | 2 |
| Goulding, NJ | 1 |
| Podgorski, MR | 1 |
| Hall, ND | 1 |
| Flower, RJ | 1 |
| Browning, JL | 1 |
| Pepinsky, RB | 1 |
| Maddison, PJ | 1 |
| Peretz, A | 1 |
| Praet, JP | 1 |
| Bosson, D | 1 |
| Rozenberg, S | 1 |
| Bourdoux, P | 1 |
| Wardman, AG | 1 |
| Simpson, FG | 1 |
| Knox, AJ | 1 |
| Page, RL | 1 |
| Bennett, J | 1 |
| Osman, J | 1 |
| Blainey, AD | 1 |
| Davies, RJ | 1 |
| James, AL | 1 |
| Ryan, G | 1 |
| Musk, AW | 1 |
| Swinburn, CR | 1 |
| Wakefield, JM | 1 |
| Newman, SP | 1 |
| Jones, PW | 1 |
| Peters, I | 1 |
| Wieland, GA | 1 |
| Lowe, JG | 1 |
| Beck, JS | 1 |
| Gibbs, JH | 1 |
| Brown, RA | 1 |
| Potts, RC | 1 |
| Grange, JM | 1 |
| Stanford, JL | 1 |
| Pantin, CF | 1 |
| Stead, RJ | 1 |
| Hodson, ME | 1 |
| Batten, JC | 1 |
| Fergusson, RJ | 1 |
| Scott, CM | 1 |
| Rafferty, P | 1 |
| Gaddie, J | 1 |
| Loft, S | 1 |
| Simonsen, K | 1 |
| Evald, T | 1 |
| Christensen, HR | 1 |
| Sonne, J | 1 |
| Døssing, M | 1 |
| Burnett, D | 1 |
| Reynolds, JJ | 1 |
| Ward, RV | 1 |
| Afford, SC | 1 |
| Stockley, RA | 1 |
| Kessler, D | 1 |
| van der Weele, LT | 1 |
| Booij-Noord, H | 2 |
| Orie, NG | 2 |
| Cegla, UH | 1 |
| Demisch, K | 1 |
| Brunt, MF | 1 |
| James, DG | 1 |
| Criep, LH | 1 |
| Dahlström, G | 1 |
| Johansson, G | 1 |
| Kiviloog, J | 1 |
| Illig, H | 1 |
| Mangold, H | 1 |
| Epstein, RL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| GR Activity in Induced Sputum Macrophages, and a Change in Inflammatory Biomarkers 2-hours After a Single Dose of Either Symbicort®/Budesonide/Formoterol or in Chronic Obstructive Pulmonary Disease (COPD)[NCT01787097] | Phase 4 | 31 participants (Actual) | Interventional | 2013-01-31 | Completed | ||
| Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid Therapy: A 4-Week, Randomized, Double-Blind, Placebo-Controlled Study[NCT01061970] | Phase 2 | 15 participants (Anticipated) | Interventional | 2007-01-31 | Completed | ||
| Personalized Variable Versus Fixed Dose Corticosteroids Therapy in Hospitalized Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease[NCT02147015] | 248 participants (Actual) | Interventional | 2014-06-30 | Completed | |||
| Phase 4 Withdrawal of Inhaled Corticosteroids in Patients With Chronic Obstructive Pulmonary Disease in Primary Care: a Randomised Controlled Trial[NCT00440687] | Phase 4 | 256 participants | Interventional | 2001-01-31 | Completed | ||
| "Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD - a Randomized, Double-blind, Non-inferiority Study (The RECUT-Trial)"[NCT02386735] | 470 participants (Anticipated) | Interventional | 2015-03-31 | Recruiting | |||
| Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)[NCT03137303] | Phase 3 | 402 participants (Actual) | Interventional | 2017-07-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Changes in CXCL8 concentrations in sputum compared to screening visit. (NCT01787097)
Timeframe: Screening visit and 2 hours post inhalation of treatment
| Intervention | ng/mL (Mean) |
|---|---|
| Formoterol (FORM) Total Dose 24ug | -0.04 |
| Symbicort® Total Dose 400ug/12ug | -2.1 |
| Symbicort® Total Dose 800ug/24ug | -2.2 |
| Pulmicort 800 | -1.5 |
Changes in IL-6 Levels in the sputum supernatant compared to screening visit (NCT01787097)
Timeframe: Screening visit and 2 hours post inhalation of treatment
| Intervention | pg/mL (Mean) |
|---|---|
| Formoterol (FORM) Total Dose 24ug | -29 |
| Symbicort® Total Dose 400ug/12ug | -14 |
| Symbicort® Total Dose 800ug/24ug | -28 |
| Pulmicort 800 | -29 |
Improvement in FEV1 compared to baseline levels. (NCT01787097)
Timeframe: Baseline and 2 hours post inhalation
| Intervention | mL (Mean) |
|---|---|
| Formoterol (FORM) Total Dose 24ug | 160 |
| Symbicort® Total Dose 400ug/12ug | 120 |
| Symbicort® Total Dose 800ug/24ug: | 200 |
| Pulmicort 800ug | 52 |
Sputum TNF-alpha levels obtained from induced sputum compared to screening visit. (NCT01787097)
Timeframe: Screening visit and 2 hours post inhalation of treatment
| Intervention | pg/mL (Mean) |
|---|---|
| Formoterol (FORM) Total Dose 24ug | -4.8 |
| Symbicort® Total Dose 400ug/12ug | -5.7 |
| Symbicort® Total Dose 800ug/24ug | -7.8 |
| Pulmicort 800ug | -9.4 |
Enzyme immunosorbent assay system (NCT01787097)
Timeframe: Screening visit and 2 hours post inhalation of treatment
| Intervention | Fold activation (Mean) |
|---|---|
| Formoterol (FORM) Total Dose 24ug | 1.1 |
| Symbicort® Total Dose 400ug/12ug | 1.8 |
| Symbicort® Total Dose 800ug/24ug | 2.3 |
| Pulmicort 800ug | 2.1 |
Determine differences in healthcare visits which include all-cause and respiratory related, acute care outpatient visits, emergency department visits, and hospitalizations between groups (NCT03137303)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emergency room visit72551318 | Emergency room visit72551317 | Hospitalization72551317 | Hospitalization72551318 | Acute outpatient visit72551318 | Acute outpatient visit72551317 | Routine primary care visits72551317 | Routine primary care visits72551318 | New diagnostic tests72551318 | New diagnostic tests72551317 | |||||||||||||||||||||
| No | Missing | Yes | ||||||||||||||||||||||||||||
| Patient Subject Usual Care | 111 | |||||||||||||||||||||||||||||
| Patient-Subject Intervention | 76 | |||||||||||||||||||||||||||||
| Patient Subject Usual Care | 119 | |||||||||||||||||||||||||||||
| Patient-Subject Intervention | 93 | |||||||||||||||||||||||||||||
| Patient Subject Usual Care | 1 | |||||||||||||||||||||||||||||
| Patient Subject Usual Care | 48 | |||||||||||||||||||||||||||||
| Patient-Subject Intervention | 17 | |||||||||||||||||||||||||||||
| Patient Subject Usual Care | 182 | |||||||||||||||||||||||||||||
| Patient-Subject Intervention | 152 | |||||||||||||||||||||||||||||
| Patient Subject Usual Care | 61 | |||||||||||||||||||||||||||||
| Patient-Subject Intervention | 35 | |||||||||||||||||||||||||||||
| Patient Subject Usual Care | 169 | |||||||||||||||||||||||||||||
| Patient-Subject Intervention | 134 | |||||||||||||||||||||||||||||
| Patient Subject Usual Care | 198 | |||||||||||||||||||||||||||||
| Patient-Subject Intervention | 138 | |||||||||||||||||||||||||||||
| Patient Subject Usual Care | 32 | |||||||||||||||||||||||||||||
| Patient-Subject Intervention | 31 | |||||||||||||||||||||||||||||
| Patient-Subject Intervention | 2 | |||||||||||||||||||||||||||||
| Patient Subject Usual Care | 126 | |||||||||||||||||||||||||||||
| Patient-Subject Intervention | 72 | |||||||||||||||||||||||||||||
| Patient Subject Usual Care | 104 | |||||||||||||||||||||||||||||
| Patient-Subject Intervention | 97 | |||||||||||||||||||||||||||||
4 reviews available for prednisolone and Lung Diseases, Obstructive
| Article | Year |
|---|---|
[Recent progress on the therapy for chronic obstructive pulmonary disease (COPD)--usefulness and practice of the step-by-step pharmacologic therapy].
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Androstadienes; Bronchodilator Agents; Choline | 1999 |
Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease.
Topics: Administration, Oral; Forced Expiratory Volume; Glucocorticoids; Humans; Lung; Lung Diseases, Obstru | 2000 |
Inhaled steroids for COPD?
Topics: Administration, Inhalation; Administration, Topical; Androstadienes; Anti-Inflammatory Agents; Fluti | 2001 |
[Diseases of the bronchopulmonary system].
Topics: Anti-Bacterial Agents; Bronchodilator Agents; Cromolyn Sodium; Humans; Lung Diseases, Obstructive; P | 1989 |
41 trials available for prednisolone and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Efficacy of oral prednisolone and dexamethasone in horses with recurrent airway obstruction in the presence of continuous antigen exposure.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Antigens; Cross-Over Studies; Dexamethasone | 2010 |
Comparison of prednisolone and dexamethasone effects in the presence of environmental control in heaves-affected horses.
Topics: Animals; Anti-Inflammatory Agents; Blood Gas Analysis; Bronchoalveolar Lavage Fluid; Dexamethasone; | 2008 |
Assessment of steroid responsiveness in patients with chronic airflow obstruction.
Topics: Administration, Oral; Aged; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; | 1982 |
Steroid responsiveness and chronic airflow obstruction.
Topics: Circadian Rhythm; Clinical Trials as Topic; Humans; Lung Diseases, Obstructive; Peak Expiratory Flow | 1982 |
Effects of prednisolone in chronic airflow limitation.
Topics: Adult; Aged; Albuterol; Clinical Trials as Topic; Double-Blind Method; Female; Forced Expiratory Vol | 1984 |
Effect of oral prednisolone on response to salbutamol and ipratropium bromide aerosols in patients with chronic airflow obstruction.
Topics: Aerosols; Aged; Albuterol; Atropine Derivatives; Clinical Trials as Topic; Drug Resistance; Drug Syn | 1983 |
Response to oral corticosteroids in chronic airflow obstruction.
Topics: Administration, Oral; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lu | 1983 |
Trials of steroids in patients with chronic airflow obstruction.
Topics: Clinical Trials as Topic; Humans; Lung Diseases, Obstructive; Prednisolone; Pulmonary Ventilation; R | 1983 |
Psychological changes and improvement in chronic airflow limitation after corticosteroid treatment.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Euphoria; Female; Humans; Lung Diseases, Obstru | 1984 |
Time course of response to prednisolone in chronic airflow obstruction.
Topics: Adult; Aged; Asthma; Bronchitis; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Peak | 1981 |
Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents; Asthma; Bacterial Infections; Double-B | 1995 |
A comparison of the effects of prednisolone and mianserin on ventilatory, exercise and psychometric parameters in patients with chronic obstructive pulmonary disease.
Topics: Aged; Anxiety; Double-Blind Method; Exercise; Female; Heart Rate; Humans; Lung Diseases, Obstructive | 1995 |
[Efficacy of high-dose beclomethasone in patients with stable chronic obstructive pulmonary disease].
Topics: Administration, Inhalation; Administration, Oral; Aged; Beclomethasone; Drug Therapy, Combination; F | 1995 |
Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels.
Topics: Administration, Inhalation; Administration, Oral; Adult; Age Factors; Asthma; Beclomethasone; Bone D | 1995 |
Double-blind crossover study of nedocromil sodium in partially reversible chronic obstructive airways disease.
Topics: Adult; Aged; Aged, 80 and over; Albuterol; Anti-Inflammatory Agents, Non-Steroidal; Beclomethasone; | 1993 |
Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obst
Topics: Administration, Inhalation; Administration, Oral; Aged; Beclomethasone; Bronchi; Drug Administration | 1993 |
Effects of long-term treatment with corticosteroids in COPD.
Topics: Administration, Inhalation; Administration, Oral; Budesonide; Double-Blind Method; Drug Therapy, Com | 1996 |
A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Adult; Aerosols; Androgens; Anti-Infla | 1996 |
Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.
Topics: Administration, Inhalation; Administration, Oral; Administration, Topical; Aged; Anti-Inflammatory A | 1997 |
The effect of oral corticosteroids on bronchodilator responses in COPD.
Topics: Aged; Aged, 80 and over; Albuterol; Bronchodilator Agents; Cross-Over Studies; Dose-Response Relatio | 1998 |
Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Administration, Oral; Aged; Anti-Inflammatory Agents; Budesonide; Double | 1998 |
[Corticosteroids].
Topics: Administration, Inhalation; Beclomethasone; Bronchitis; Bronchodilator Agents; Female; Glucocorticoi | 1998 |
The importance of serum IgE for level and longitudinal change in airways hyperresponsiveness in COPD.
Topics: Aged; Anti-Inflammatory Agents; Bronchial Hyperreactivity; Bronchial Provocation Tests; Budesonide; | 1998 |
Analysis of scintigraphical lung images before and after treatment of horses suffering from chronic pulmonary disease.
Topics: Aerosols; Animals; Anti-Inflammatory Agents; Blood Gas Analysis; Cephalosporins; Horse Diseases; Hor | 1999 |
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bronchodilator Agents; Drug Therapy, Combinat | 1999 |
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bronchodilator Agents; Drug Therapy, Combinat | 1999 |
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bronchodilator Agents; Drug Therapy, Combinat | 1999 |
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bronchodilator Agents; Drug Therapy, Combinat | 1999 |
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bronchodilator Agents; Drug Therapy, Combinat | 1999 |
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bronchodilator Agents; Drug Therapy, Combinat | 1999 |
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bronchodilator Agents; Drug Therapy, Combinat | 1999 |
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bronchodilator Agents; Drug Therapy, Combinat | 1999 |
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bronchodilator Agents; Drug Therapy, Combinat | 1999 |
Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Budesonide; Double-Blind Method; Forced Expirator | 1999 |
Additive effects of prednisolone and beclomethasone dipropionate in patients with stable chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Administration, Oral; Aged; Anti-Inflammatory Agents; Beclomethasone; Cr | 2000 |
Adverse effects of oral corticosteroids in relation to dose in patients with lung disease.
Topics: Administration, Oral; Aged; Asthma; Cross-Sectional Studies; Dose-Response Relationship, Drug; Femal | 2001 |
Response to oral corticosteroid in patients with chronic obstructive pulmonary disease.
Topics: Aged; Albuterol; Eosinophils; Female; Forced Expiratory Volume; Humans; Immunoglobulin E; Ipratropiu | 1992 |
A pharmacokinetic and pharmacodynamic comparison of plain and enteric-coated prednisolone tablets.
Topics: Adult; Aged; Blood Glucose; Eosinophils; Female; Humans; Hydrocortisone; Leukocyte Count; Lung Disea | 1992 |
Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation.
Topics: Aged; Double-Blind Method; Female; Fenoterol; Home Care Services; Humans; Ipratropium; Lung Diseases | 1992 |
Response to corticosteroids in chronic airflow obstruction: relationship to emphysema and airways collapse.
Topics: Administration, Inhalation; Aged; Beclomethasone; Double-Blind Method; Female; Forced Expiratory Vol | 1991 |
Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate.
Topics: Administration, Inhalation; Administration, Oral; Beclomethasone; Double-Blind Method; Female; Human | 1990 |
Time course of response to oral and inhaled corticosteroids in non-asthmatic chronic airflow obstruction.
Topics: Administration, Inhalation; Administration, Oral; Beclomethasone; Double-Blind Method; Humans; Lung | 1990 |
Limitations of simple spirometry.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Lung Diseases, Obstructive; Peak Expiratory F | 1986 |
The use of high dose inhaled beclomethasone dipropionate as a means of assessing steroid responsiveness in obstructive airways disease.
Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Aged, 80 and over; Beclomethasone; Cl | 1988 |
A double-blind comparison of oral prednisolone 40 mg/day with inhaled beclomethasone dipropionate 1500 ug/day in patients with adult onset chronic obstructive airways disease.
Topics: Aged; Beclomethasone; Double-Blind Method; Female; Humans; Lung; Lung Diseases, Obstructive; Male; M | 1986 |
Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis.
Topics: Adolescent; Adult; Clinical Trials as Topic; Cystic Fibrosis; Female; Forced Expiratory Flow Rates; | 1986 |
Value of serial peak expiratory flow measurements in assessing treatment response in chronic airflow limitation.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lung; Lung Diseases, Obstructiv | 1986 |
[Reports on long-term treatments with sintisone (prednisolon-stearoylglycolate)].
Topics: Arthritis, Rheumatoid; Asthma; Behcet Syndrome; Clinical Trials as Topic; Drug Evaluation; Eosinophi | 1974 |
[Prednisolone and Auxiloson in the asthmatic syndrome].
Topics: Adult; Aged; Airway Resistance; Asthma; Dexamethasone; Female; Humans; Isonicotinic Acids; Lung Dise | 1972 |
58 other studies available for prednisolone and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Steroids and antihistamines synergize to inhibit rat's airway smooth muscle contractility.
Topics: Animals; Cetirizine; Cholinergic Agents; Disease Models, Animal; Drug Synergism; Electric Stimulatio | 2015 |
Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Canada; Eosinophilia; Exanthema; Hepatit | 2003 |
Recovery of plasma corticotrophin and cortisol levels after three-week course of prednisolone.
Topics: Adrenal Cortex Function Tests; Adrenocorticotropic Hormone; Female; Humans; Hydrocortisone; Hypothal | 1981 |
Bilateral rupture of the Achilles tendon in patients on steroid therapy.
Topics: Achilles Tendon; Aged; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Polymyalgia Rheumatica | 1983 |
Study of the effect of small dose of steroid to ephedrine--theophylline combination in chronic obstructive pulmonary disease.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ephedrine; Female; H | 1983 |
The complications of systemic corticosteroid therapy in the elderly. A retrospective study.
Topics: Age Factors; Aged; Arthritis, Rheumatoid; Colitis, Ulcerative; Dose-Response Relationship, Drug; Fem | 1984 |
Asthma and irreversible airflow obstruction.
Topics: Adult; Age Factors; Albuterol; Asthma; Chronic Disease; Female; Forced Expiratory Volume; Humans; Lu | 1984 |
Testosterone levels during systemic and inhaled corticosteroid therapy.
Topics: Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; Beclomethaso | 1994 |
Sternomastoid muscle fatigue and twitch maximum relaxation rate in patients with steroid dependent asthma.
Topics: Aged; Asthma; Chronic Disease; Exercise; Female; Humans; Lung; Lung Diseases, Obstructive; Male; Mid | 1993 |
Obstructive pulmonary disease in 18 horses at summer pasture.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Bronchodilato | 1996 |
Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Arthritis | 1996 |
Compliance with oral corticosteroids during steroid trials in chronic airways obstruction.
Topics: Adult; Aged; Biomarkers; Female; Glucocorticoids; Humans; Lung Diseases, Obstructive; Male; Middle A | 1996 |
Cardiovascular responses to tests for autonomic dysfunction in patients with chronic obstructive pulmonary disease with and without continuous long-term oxygen therapy.
Topics: Adult; Aged; Autonomic Nervous System Diseases; Blood Gas Analysis; Blood Pressure; Cardiovascular P | 1996 |
Long-term follow-up of pulmonary function in chronic eosinophilic pneumonia. Groupe d'Etude en Pathologie Interstitielle de la Société de Pathologie Thoracique du Nord.
Topics: Adult; Aged; Aged, 80 and over; Bronchoalveolar Lavage Fluid; Chronic Disease; Eosinophils; Female; | 1997 |
Plasma levels of leukotriene E4 during clinical course of chronic obstructive pulmonary disease.
Topics: Adult; Aged; Case-Control Studies; Forced Expiratory Volume; Glucocorticoids; Humans; Leukotriene E4 | 1997 |
Importance of sputum differential cell counting in the diagnosis of airway diseases.
Topics: Adolescent; Adult; Aged; Asthma; Cell Count; Child; Cough; Heart Failure; Humans; Lung Diseases, Obs | 1997 |
Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease.
Topics: Adrenergic beta-Agonists; Aged; Antioxidants; Bronchodilator Agents; Chromans; Drug Therapy, Combina | 1997 |
The effect of large-dose prednisolone on patients with obstructive lung disease associated with consuming sauropus androgynus.
Topics: Adult; Female; Humans; Lung Diseases, Obstructive; Middle Aged; Prednisolone; Retrospective Studies; | 1998 |
Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy.
Topics: Administration, Oral; Aged; Cohort Studies; Cross-Sectional Studies; Endocrine Glands; Glucocorticoi | 1998 |
[Increased concentration of Na,K-pumps in skeletal muscles of patients with chronic obstructive lung disease. Significance of magnesium depletion and treatment with glucocorticoids].
Topics: Adult; Aged; Anti-Inflammatory Agents; Diuretics; Female; Glucocorticoids; Humans; Lung Diseases, Ob | 1998 |
Sequentially induced sputum in patients with asthma or chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Administration, Oral; Adrenergic beta-Agonists; Adult; Aged; Albuterol; | 1999 |
Oral corticosteroid trials in the management of stable chronic obstructive pulmonary disease.
Topics: Administration, Oral; Adrenergic beta-Agonists; Albuterol; Analysis of Variance; Beclomethasone; Dru | 1999 |
Feasibility of spirometry and reversibility testing for the identification of patients with chronic obstructive pulmonary disease on asthma registers in general practice.
Topics: Aged; Anti-Asthmatic Agents; Asthma; Beclomethasone; Bronchodilator Agents; Cross-Sectional Studies; | 1999 |
Inhaled fluticasone.
Topics: Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Diagnosis, Differential; Fl | 2000 |
Muscle metabolic status in patients with severe COPD with and without long-term prednisolone.
Topics: Aged; Cross-Sectional Studies; Dose-Response Relationship, Drug; Energy Metabolism; Glucocorticoids; | 2000 |
Response to prednisolone in COPD.
Topics: Anti-Inflammatory Agents; Climate; Eosinophils; Humans; Lung Diseases, Obstructive; Prednisolone; Sp | 2001 |
The relationship between the arterial level of angiotensin-converting enzymes and arterial gas tension in bronchial asthma.
Topics: Asthma; Blood Gas Analysis; Chronic Disease; Humans; Hydrogen-Ion Concentration; Hypoxia; Lung Disea | 1979 |
[Learning by doing].
Topics: Adult; Beclomethasone; Bis-Trimethylammonium Compounds; Bronchial Neoplasms; Carcinoma, Small Cell; | 1977 |
[Long term experiences following switching from oral administration to corticosteroid inhalation in patients with chronic aspecific lung diseases].
Topics: Administration, Oral; Adult; Aged; Beclomethasone; Blood Glucose; Blood Pressure; Body Weight; Eosin | 1979 |
[Venous thrombosis during long-term corticoid therapy in chronic obstructive lung diseases].
Topics: Adult; Female; Humans; Leg; Lung Diseases, Obstructive; Male; Middle Aged; Prednisolone; Risk; Throm | 1979 |
Acute bronchodilator trials in chronic obstructive pulmonary disease.
Topics: Aerosols; Aged; Aging; Albuterol; Bronchodilator Agents; Drug Evaluation; Female; Forced Expiratory | 1992 |
Bone turnover during short course prednisolone treatment in patients with chronic obstructive airways disease.
Topics: Aged; Bone and Bones; Bone Resorption; Creatinine; Humans; Hydroxyproline; Lung Diseases, Obstructiv | 1992 |
[Chronic disseminated lung diseases: diagnostic and therapeutic tactics].
Topics: Adrenal Cortex Hormones; Diagnosis, Differential; Humans; Immunosuppressive Agents; Lung Diseases; L | 1992 |
Steroid trials in the assessment of reversibility of air flow limitation: a survey of current clinical practice of chest physicians.
Topics: Chronic Disease; Humans; Lung; Lung Diseases, Obstructive; Prednisolone; Pulmonary Ventilation; Resp | 1991 |
Genetically determined coincidence of Kaposi sarcoma and psoriasis in an HIV-negative patient after prednisolone treatment. Spontaneous regression 8 months after discontinuing therapy.
Topics: Disease Susceptibility; HIV Seropositivity; HLA Antigens; Humans; Lung Diseases, Obstructive; Male; | 1991 |
[Does COPD affect bone mineral content?].
Topics: Aged; Bone Density; Female; Humans; Long-Term Care; Lung Diseases, Obstructive; Male; Middle Aged; P | 1990 |
Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
Topics: Airway Resistance; Albuterol; Humans; Lung Diseases, Obstructive; Prednisolone | 1990 |
Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
Topics: Albuterol; Female; Forced Expiratory Volume; Humans; Lung; Lung Diseases, Obstructive; Male; Middle | 1990 |
Purpura and dermal thinning associated with high dose inhaled corticosteroids.
Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Atrophy; Beclomethasone; Cross-Sectio | 1990 |
Oral corticosteroids and histamine releasability of basophil granulocytes.
Topics: Administration, Oral; Female; Granulocytes; Histamine Release; Humans; Lung Diseases, Obstructive; M | 1988 |
Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosus.
Topics: Aged; Annexins; Arthritis, Rheumatoid; Autoantibodies; Calcium-Binding Proteins; Enzyme-Linked Immun | 1989 |
Serum osteocalcin in the assessment of corticosteroid induced osteoporosis. Effect of long and short term corticosteroid treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Calcium-Binding Proteins; Co | 1989 |
The assessment of a computer administered questionnaire in the differential diagnosis of asthma and chronic airflow limitation.
Topics: Adult; Aged; Albuterol; Asthma; Bronchi; Bronchial Provocation Tests; Diagnosis, Computer-Assisted; | 1988 |
Bronchial responsiveness, lung mechanics, gas transfer, and corticosteroid response in patients with chronic airflow obstruction.
Topics: Airway Resistance; Bronchial Provocation Tests; Forced Expiratory Volume; Humans; Lung; Lung Disease | 1988 |
Evidence of prednisolone induced mood change ('steroid euphoria') in patients with chronic obstructive airways disease.
Topics: Aged; Albuterol; Emotions; Euphoria; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; M | 1988 |
Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction?
Topics: Adult; Female; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Pred | 1988 |
Skin test responsiveness to four new tuberculins in patients with chronic obstructive airways disease receiving short term high doses of, or long term maintenance treatment with, prednisolone: clinical appearances and histometric studies.
Topics: Aged; Drug Administration Schedule; Erythema; Female; Humans; Leukocyte Count; Lung Diseases, Obstru | 1987 |
Effect of prednisolone on theophylline pharmacokinetics in patients with chronic airflow obstruction.
Topics: Aged; Aminophylline; Drug Interactions; Female; Half-Life; Humans; Kinetics; Lung Diseases, Obstruct | 1987 |
Influence of prednisolone on antipyrine elimination in patients with obstructive lung disease.
Topics: Antipyrine; Female; Humans; Liver; Lung Diseases, Obstructive; Male; Metabolic Clearance Rate; Middl | 1987 |
Tissue inhibitor of metalloproteinases and collagenase inhibitory activity in lung secretions from patients with chronic obstructive bronchitis: effect of corticosteroid treatment.
Topics: Enzyme Inhibitors; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Prednisolone; Sput | 1986 |
[Osteoporosis in corticoid therapy of patients with chronic obstructive respiratory tract diseases].
Topics: Adrenal Cortex Hormones; Adult; Dose-Response Relationship, Drug; Female; Humans; Long-Term Care; Lu | 1985 |
Severe chronic airflow obstruction: can corticosteroids slow down progression?
Topics: Female; Forced Expiratory Volume; Humans; Longitudinal Studies; Lung Diseases, Obstructive; Male; Mi | 1985 |
Late bronchial obstructive reaction to experimental inhalation of house dust extract.
Topics: Adolescent; Adult; Benzyl Compounds; Body Temperature; Bronchial Diseases; Cromolyn Sodium; Dust; Eo | 1972 |
[Combined corticosteroid and synthetic depot ACTH therapy in chronic obstructive ventilation disorders].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Female; Humans; Hydrocortisone; Lung Di | 1973 |
Corticoid therapy in chronic obstructive pulmonary disease.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adrenal Glands; Aerosols; Aged; Chronic Disease; Circ | 1973 |
Immunoglobulin IgE concentrations in an adult clinical material with chronic obstructive pulmonary disease.
Topics: Adolescent; Adult; Aged; Asthma; Bronchitis; Female; Humans; Immunoglobulin E; Lung Diseases, Obstru | 1973 |
Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone.
Topics: Allergens; Bronchial Spasm; Chromones; Cromolyn Sodium; Dust; Environmental Exposure; Eosinophils; H | 1971 |
Sputum eosinophilia in obstructive lung disease.
Topics: Airway Obstruction; Eosinophilia; Humans; Lung Diseases; Lung Diseases, Obstructive; Prednisolone; S | 1971 |